Research indicates that dilated cardiomyopathy can be caused by the cumulative influence of potentially thousands of genes, not just one single genetic variant.
Aim The aim of this study was to characterize an alternative treatment for dilated cardiomyopathy (DCM) using a novel cardiac biological assist device created from engineered heart tissue (EHT).